Search for: "SUNOVION PHARMACEUTICALS INC. " Results 1 - 20 of 20
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Apr 2012, 9:49 pm by Patent Docs
Sunovion Pharmaceuticals Inc., the Federal Circuit affirmed a District Court's conclusion that it had subject-matter jurisdiction over a declaratory judgment action of a second ANDA filer, and as a result also affirmed the District Court's final judgment of non-infringement (based on a stipulation of the parties). [read post]
5 Aug 2012, 7:54 pm by Patent Docs
Sunovion Pharmaceuticals Inc. v. [read post]
30 May 2013, 1:00 am by Courtenay Brinckerhoff
Sunovion Pharmaceuticals, Inc., the Federal Circuit vacated the district court’s grant of summary judgment in favor of Sunovion, and remanded for further consideration of whether Sunovion’s clinical trial constituted a “public use” of the formulation claimed... [read post]
17 Feb 2012, 10:25 am by Robert Vrana
The jury recently reached a verdict of validity and willful infringement against the defendants in Sunovion Pharmaceuticals Inc. v. [read post]
27 Sep 2013, 5:47 am by Lawrence B. Ebert
Reddy'sThe CAFC reversed:Sunovion Pharmaceuticals, Inc. [read post]
15 May 2012, 1:00 am by Courtenay Brinckerhoff
Sunovion Pharmaceuticals, Inc., the Federal Circuit affirmed the district court’s determination that it could exercise jurisdiction over a declaratory judgment action brought by a subsequent ANDA filer. [read post]
5 Mar 2014, 8:57 pm
   Procedural HistoryDuring the late 1990s and 2000s, Sunovion Pharmaceuticals, Inc., and the Dey plaintiffs . . . were simultaneously developing pharmaceutical products to treat lung disease. [read post]
3 Oct 2014, 10:22 am by Nicolette Koozer
Bartz, State and Federal Communications, Inc.; and Katrina Iserman, Sunovion Pharmaceuticals. [read post]
21 Oct 2011, 7:40 am by Phil
Sepracor, now known as Sunovion Pharmaceuticals, requested the PTO to re-examine these patents, which now has been completed. [read post]
1 Apr 2014, 7:21 am by Nicolette Koozer
 Elizabeth and Katrina Iserman from Sunovion Pharmaceuticals attending the Democratic Governor’s Association [DGA] reception at Mayflower Hotel during NGA Winter Meeting in Washington, D.C. [read post]
17 Nov 2010, 9:00 am by Lucas A. Ferrara, Esq.
  Latuda is manufactured by Sunovion Pharmaceuticals Inc. of Fort Lee, N.J. [read post]
8 Dec 2010, 2:20 am by Marie Louise
Allergan, Inc (Docket Report) Products Enbrel (Etanercept) – Israel: Patent status in question, in need of legislative fix (America-Israel Patent Law) Fabrazyme (Alpha-galactosidase) – US: Statements by KEI and others on NIH rejection of Fabrazyme march-in request (KEI) Intuniv (Guanfacine) – US: Impax confirms patent challenge relating to Intuniv (GenericsWeb) Lovenox (Enoxaparin) – US: Momenta sues Teva over claims relating to ways of manufacturing and analysing… [read post]
11 Aug 2017, 9:09 am by Rachel Sandler
Teva Pharmaceuticals, suggests the court will not impose a secret commercial use or secret sale exception to the public use and on sale bars.[26] In Helsinn Healthcare, the Federal Circuit recognized that “such floor statements are typically not reliable indicators of congressional intent. [read post]